X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/04/01/2855070/0/en/Sol-Gel-s-Collaboration-Partner-First-to-File-ANDA-Drug-Product-Generic-to-Zoryve-Cream.html
https://www.globenewswire.com/news-release/2023/01/27/2596798/0/en/Sol-Gel-Acquires-Patidegib-a-Phase-3-FDA-Breakthrough-Designated-Orphan-Product-Candidate-to-Pursue-Potential-Market-of-Over-300-Million.html
https://www.pharmacompass.com/pdf/news/pellepharm-to-highlight-clinical-programs-at-the-29th-congress-1605859136.pdf
https://www.businesswire.com/news/home/20190401005258/en/PellePharm-Initiates-Pivotal-Phase-3-Clinical-Trial/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.businesswire.com/news/home/20190131005847/en/Phyton-Biotech-Partners-PellePharm-Develop-Renewable-Supply
Market Place
Share 
